NCT01597323 is a clinical trial in Skin Texture Irregularities, sponsored by Candela Corporation.

Who is sponsoring NCT01597323?

NCT01597323 is sponsored by Candela Corporation.

What condition does NCT01597323 study?

NCT01597323 studies Skin Texture Irregularities, Facial Skin Wrinkles.

Is NCT01597323 still recruiting?

NCT01597323 is currently completed. Last updated 6 December 2019.

Last reviewed 2019-12-06 · How we verify

NCT01597323

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture

Completed Last updated 6 December 2019

What this trial tests

trial in Skin Texture Irregularities in 61 participants. Completed in 14 October 2014.

Timeline

25 October 2011

Primary endpoint
14 October 2014

14 October 2014

Quick facts

Lead sponsor	Candela Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	61
Start date	25 October 2011
Primary completion	14 October 2014
Estimated completion	14 October 2014
Sites	3 locations across United States

Conditions studied

Skin Texture Irregularities — all drugs for Skin Texture Irregularities →
Facial Skin Wrinkles — all drugs for Facial Skin Wrinkles →

Sponsor

Candela Corporation — full company profile →

Who can join

Adults 35 to 60, any sex, with Skin Texture Irregularities or Facial Skin Wrinkles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the clinical performance, safety and efficacy, of a Radiofrequency and Laser/Light based device for the treatment of facial wrinkles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Candela Corporation trials

Trials by the same sponsor.

NCT06219278 — A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles · completed
NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting
NCT06157567 — Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System · NA · active not recruiting
NCT04975243 — Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro™/GentleMax Pro Plus™ · NA · unknown
NCT04993066 — Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01597323 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Candela Corporation
Last refreshed: 6 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01597323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing